Published in Am J Infect Control on February 27, 2013
Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol (2014) 1.64
Incidence of Surgical Site Infection Following Mastectomy With and Without Immediate Reconstruction Using Private Insurer Claims Data. Infect Control Hosp Epidemiol (2015) 0.86
Stratification of surgical site infection by operative factors and comparison of infection rates after hernia repair. Infect Control Hosp Epidemiol (2015) 0.84
Prevention of surgical site infection: beyond SCIP. AORN J (2014) 0.81
Seasonal Variation of Common Surgical Site Infections: Does Season Matter? Infect Control Hosp Epidemiol (2015) 0.80
Development of a Risk Prediction Model to Individualize Risk Factors for Surgical Site Infection After Mastectomy. Ann Surg Oncol (2016) 0.78
Compliance with Standard Precautions and Associated Factors among Healthcare Workers in Gondar University Comprehensive Specialized Hospital, Northwest Ethiopia. J Environ Public Health (2017) 0.75
Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable. Clinicoecon Outcomes Res (2016) 0.75
Epidemiology of Surgical Site Infection in a Community Hospital Network. Infect Control Hosp Epidemiol (2016) 0.75
Risk Factors for Surgical Site Infection After Cholecystectomy. Open Forum Infect Dis (2017) 0.75
Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep (2007) 11.94
The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol (1999) 6.72
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol (2005) 5.86
Hospital volume and the outcomes of mechanical ventilation. N Engl J Med (2006) 5.67
National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control (2009) 3.91
Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol (2011) 3.60
Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol (1996) 2.99
Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol (2011) 2.71
Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist (2007) 2.43
Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.22
Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection? Infect Control Hosp Epidemiol (2009) 1.86
Surveillance bias in outcomes reporting. JAMA (2011) 1.78
Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol (2007) 1.16
Completeness of surveillance data reported by the National Healthcare Safety Network: an analysis of healthcare-associated infections ascertained in a tertiary care hospital, 2010. Infect Control Hosp Epidemiol (2011) 1.00
Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections. Med Care (1987) 0.99
Surgical volume and the risk of surgical site infection in community hospitals: size matters. Ann Surg (2008) 0.91
The dilemma of assessment bias in infection control research. Clin Infect Dis (2012) 0.89
The epidemiology of ventilator-associated pneumonia in a network of community hospitals: a prospective multicenter study. Infect Control Hosp Epidemiol (2013) 0.88
CMS reveals Medicare's value-based purchasing program for hospitals. Am J Health Syst Pharm (2011) 0.82
Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med (2002) 4.75
Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. Am J Infect Control (2005) 4.02
SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect Control Hosp Epidemiol (2010) 3.44
Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol (2003) 2.93
S100A4, a mediator of metastasis. J Biol Chem (2005) 2.68
Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med (2002) 2.41
Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis (2004) 2.01
Impact of vaginal-rectal ultrasound examinations with covered and low-level disinfected transducers on infectious transmissions in france. Infect Control Hosp Epidemiol (2014) 1.98
Guideline for disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol (2010) 1.95
Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control (2010) 1.91
Room decontamination with UV radiation. Infect Control Hosp Epidemiol (2010) 1.76
Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol (2003) 1.72
Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol (2009) 1.70
Multisociety guideline on reprocessing flexible gastrointestinal endoscopes: 2011. Gastrointest Endosc (2011) 1.69
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64
The benefits of surface disinfection. Am J Infect Control (2004) 1.58
Lessons learned from outbreaks and pseudo-outbreaks associated with bronchoscopy. Infect Control Hosp Epidemiol (2012) 1.51
Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients. Infect Control Hosp Epidemiol (2011) 1.48
Challenges of antibiotic prescribing for assisted living residents: perspectives of providers, staff, residents, and family members. J Am Geriatr Soc (2013) 1.41
Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction. J Med Chem (2004) 1.41
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol (2008) 1.41
Self-disinfecting surfaces. Infect Control Hosp Epidemiol (2011) 1.40
Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol (2010) 1.39
A case of triplicate publication. Am J Med (2002) 1.39
The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis (2013) 1.39
Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells. J Biol Chem (2004) 1.38
Molecular mechanisms of S100-target protein interactions. Microsc Res Tech (2003) 1.37
Utility of International Classification of Diseases, Ninth Revision, Clinical Modification codes for communicable disease surveillance. Am J Epidemiol (2010) 1.36
Prospective study of etiologic agents of acute gastroenteritis outbreaks in child care centers. J Pediatr (2008) 1.31
Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. PLoS One (2012) 1.30
The three-dimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy. J Mol Biol (2005) 1.29
Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Res (2009) 1.29
Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12. J Mol Biol (2002) 1.25
Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B. Biochim Biophys Acta (2006) 1.24
Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrob Agents Chemother (2007) 1.23
S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling. J Biol Chem (2007) 1.23
S100A1 and calmodulin compete for the same binding site on ryanodine receptor. J Biol Chem (2008) 1.23
Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women. Am J Epidemiol (2006) 1.19
Bacterial contamination of keyboards: efficacy and functional impact of disinfectants. Infect Control Hosp Epidemiol (2006) 1.19
Development of a treatment algorithm for streptococci and enterococci from positive blood cultures identified with the Verigene Gram-positive blood culture assay. J Clin Microbiol (2013) 1.17
Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol (2007) 1.16
Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53. Biochemistry (2005) 1.14
Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol (2014) 1.13
Solution structure of human Mts1 (S100A4) as determined by NMR spectroscopy. Biochemistry (2002) 1.11
Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages. Infect Control Hosp Epidemiol (2005) 1.11
Structure of Ca2+-bound S100A4 and its interaction with peptides derived from nonmuscle myosin-IIA. Biochemistry (2008) 1.10
Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua. Pediatr Infect Dis J (2014) 1.10
Patterns of rotavirus vaccine uptake and use in privately-insured US infants, 2006-2010. PLoS One (2013) 1.09
Divalent metal ion complexes of S100B in the absence and presence of pentamidine. J Mol Biol (2008) 1.09
How to assess risk of disease transmission to patients when there is a failure to follow recommended disinfection and sterilization guidelines. Infect Control Hosp Epidemiol (2007) 1.09
Central line-associated bloodstream infections: prevention and management. Infect Dis Clin North Am (2011) 1.08
On contact precautions: the good, the bad, and the ugly. Infect Control Hosp Epidemiol (2014) 1.08
Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands. JAMA (2003) 1.07
Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm (2012) 1.07
Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance? Infect Control Hosp Epidemiol (2006) 1.07
Restriction endonuclease inhibitor IPI* of bacteriophage T4: a novel structure for a dedicated target. J Mol Biol (2007) 1.07
Three-dimensional solution structure of the calcium-signaling protein apo-S100A1 as determined by NMR. Biochemistry (2002) 1.06
A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV. AIDS (2003) 1.05
The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma. J Biol Chem (2010) 1.04
Lessons learned: protection of healthcare workers from infectious disease risks. Crit Care Med (2010) 1.03
Phenothiazines inhibit S100A4 function by inducing protein oligomerization. Proc Natl Acad Sci U S A (2010) 1.03
Compliance with isolation precautions at a university hospital. Infect Control Hosp Epidemiol (2007) 1.02
Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities. Antimicrob Agents Chemother (2006) 1.02
Effects of air temperature and relative humidity on coronavirus survival on surfaces. Appl Environ Microbiol (2010) 1.01
The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography. J Mol Biol (2010) 1.01
An N-terminal sequence targets and tethers Na+ pump alpha2 subunits to specialized plasma membrane microdomains. J Biol Chem (2006) 1.01
Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailty. Med Care (2013) 1.01
A quantitative approach to defining "high-touch" surfaces in hospitals. Infect Control Hosp Epidemiol (2010) 1.01
Completeness of communicable disease reporting, North Carolina, USA, 1995-1997 and 2000-2006. Emerg Infect Dis (2011) 1.00
Completeness of surveillance data reported by the National Healthcare Safety Network: an analysis of healthcare-associated infections ascertained in a tertiary care hospital, 2010. Infect Control Hosp Epidemiol (2011) 1.00
Syndromic surveillance for emerging infections in office practice using billing data. Ann Fam Med (2006) 0.98
Solution structure of S100A1 bound to the CapZ peptide (TRTK12). J Mol Biol (2009) 0.97
Post-transcriptional regulation of thioredoxin by the stress inducible heterogenous ribonucleoprotein A18. Nucleic Acids Res (2006) 0.97
Disinfectants used for environmental disinfection and new room decontamination technology. Am J Infect Control (2013) 0.96
Solution structure of zinc- and calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy. Biochemistry (2005) 0.96
Using hospital antibiogram data to assess regional pneumococcal resistance to antibiotics. Emerg Infect Dis (2003) 0.95
S100A1: Structure, Function, and Therapeutic Potential. Curr Chem Biol (2009) 0.95
Understanding and preventing transmission of healthcare-associated pathogens due to the contaminated hospital environment. Infect Control Hosp Epidemiol (2013) 0.94
Etiology of childhood diarrhea after rotavirus vaccine introduction: a prospective, population-based study in Nicaragua. Pediatr Infect Dis J (2014) 0.94
Prevalence and risk factor analysis for methicillin-resistant Staphylococcus aureus nasal colonization in children attending child care centers. J Clin Microbiol (2010) 0.94
Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010. Am J Epidemiol (2014) 0.94
Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol (2014) 0.94
Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device. Infect Control Hosp Epidemiol (2013) 0.94
The effects of test variables on the efficacy of hand hygiene agents. Am J Infect Control (2004) 0.94
Successfully reducing antibiotic prescribing in nursing homes. J Am Geriatr Soc (2014) 0.93
Multisociety guideline on reprocessing flexible GI endoscopes: 2011. Infect Control Hosp Epidemiol (2011) 0.92
Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis. Biochemistry (2003) 0.92
Community diarrhea incidence before and after rotavirus vaccine introduction in Nicaragua. Am J Trop Med Hyg (2013) 0.91
Comparison of hospitalwide surveillance and targeted intensive care unit surveillance of healthcare-associated infections. Infect Control Hosp Epidemiol (2007) 0.91
Olfactory marker protein (OMP) exhibits a beta-clam fold in solution: implications for target peptide interaction and olfactory signal transduction. J Mol Biol (2002) 0.91
Virus transfer from personal protective equipment to healthcare employees' skin and clothing. Emerg Infect Dis (2008) 0.91
Solution structure of the novel dispersin protein of enteroaggregative Escherichia coli. Mol Microbiol (2007) 0.91